key: cord-0426010-w197zkg6
authors: Makoto, Ujike; Yuka, Etoh; Naoya, Urushiyama; Fumihiro, Taguchi; Luis, Enjuanes; Wataru, Kamitani
title: Reverse Genetics with a Full-length Infectious cDNA Clone of Bovine Torovirus
date: 2020-10-28
journal: bioRxiv
DOI: 10.1101/2020.10.28.358754
sha: 1d75303c31bbe826b1281bf0026c0f5e3249ffb9
doc_id: 426010
cord_uid: w197zkg6

Torovirus (ToV) has recently been classified in the new family Tobaniviridae, although it belonged to the Coronavirus (CoV) family historically. Reverse genetics systems for many CoVs have been established, but none exist for ToVs. Here, we describe a reverse genetics system using a full-length infectious cDNA clone of bovine ToV (BToV) in a bacterial artificial chromosome (BAC). Recombinant BToV containing genetic markers had the same phenotype as wild-type (wt) BToV. To generate two types of recombinant virus, the Hemagglutinin-esterase (HE) gene was manipulated, since cell-adapted wtBToV generally loses the full-length HE (HEf), resulting in soluble HE (HEs). First, recombinant viruses with HEf and HA-tagged HEf or HEs genes were rescued; these showed no significant differences in cell growth, suggesting that HE is not essential for viral growth in cells. Then, recombinant virus in which HE was replaced by the Enhanced Green Fluorescent Protein (EGFP) gene expressed EGFP in infected cells, but showed significantly reduced viral growth compared to wtBToV. Moreover, the recombinant virus readily deleted the EGFP gene after one passage. Interestingly, one variant with mutations in non-structural proteins (NSPs) showed improved EGFP expression and viral growth during serial passages, although it eventually deleted the EGFP gene, suggesting that these mutations contributed to EGFP gene acceptance. These recombinant viruses provide new insights regarding BToV and its reverse genetics will help advance understanding of this neglected pathogen. Importance ToVs are diarrhea-causing pathogens that have been detected in many species, including humans. BToV has spread worldwide, leading to economic losses. We developed the first reverse genetics system for Tobaniviridae using a BAC-based BToV. Using this system, we showed that recombinant BToVs with HEf and HEs showed no significant differences in cell growth. In contrast, clinical BToVs generally lose the HE gene after a few passages but some recombinant viruses retained the HE gene for up to 20 passages, suggesting some benefits of HE retention. The EGFP gene of the recombinant viruses was unstable and was rapidly deleted, likely via negative selection. Interestingly, one virus variant with mutations in NSPs was more stable, resulting in improved EGFP-expression and viral growth, suggesting that the mutations contributed to some acceptance of the exogenous EGFP gene without clear positive selection. The recombinant BToVs and reverse genetics developed here are powerful tools for understanding fundamental viral processes and their pathogenesis and for developing BToV vaccines.

Torovirus (ToV) has recently been classified in the new family Tobaniviridae, although it belonged to the 23 Coronavirus (CoV) family historically. Reverse genetics systems for many CoVs have been established, but 24 none exist for ToVs. Here, we describe a reverse genetics system using a full-length infectious cDNA clone of 25 bovine ToV (BToV) in a bacterial artificial chromosome (BAC). Recombinant BToV containing genetic markers 26 had the same phenotype as wild-type (wt) BToV. To generate two types of recombinant virus, the 27 Hemagglutinin-esterase (HE) gene was manipulated, since cell-adapted wtBToV generally loses the full-28 length HE (HEf), resulting in soluble HE (HEs). First, recombinant viruses with HEf and HA-tagged HEf or 29 HEs genes were rescued; these showed no significant differences in cell growth, suggesting that HE is not 30 essential for viral growth in cells. Then, recombinant virus in which HE was replaced by the Enhanced Green 31 Fluorescent Protein (EGFP) gene expressed EGFP in infected cells, but showed significantly reduced viral 32 growth compared to wtBToV. Moreover, the recombinant virus readily deleted the EGFP gene after one 33 passage. Interestingly, one variant with mutations in non-structural proteins (NSPs) showed improved EGFP 34 expression and viral growth during serial passages, although it eventually deleted the EGFP gene, suggesting 35 that these mutations contributed to EGFP gene acceptance. These recombinant viruses provide new insights 36 regarding BToV and its reverse genetics will help advance understanding of this neglected pathogen. In contrast to CoVs, only few studies of ToVs have been conducted, and no reverse genetics systems have 89 been established since many ToVs are difficult to propagate in cells, and because less attention has been paid 90

to ToVs as ToV infections are generally asymptomatic or not severe. In this study, we describe a reverse 91 genetic system for BToV (Aichi strain) based on the cloning of a full-length genomic cDNA into BAC. Using 92 this system, recombinant viruses with HA-tagged HE gene, untagged full-length HE gene, or with EGFP 93 gene, were successfully rescued by manipulating the HE gene; these viruses were then characterized. 94

Full-length genome sequence of wild-type (wt) BToV. 98

To determine the parent BToV (Aichi strain) for reverse genetics, the full-length genomic sequences of three 99 plaque-purified BToV were analyzed. We tried to determine the 5' terminal end of these viruses using the 5' 100 RACE method, but several different sequences were observed in the terminal three bases; 5'-TGACGT-3', 5'-101

GTACGT-3', 5'-GGACGT-3', 5'-GACGT-3', 5'-ACGT-3', 5'-(-)CGT-3'. The sequence at the 5' terminal end of 102 three published BToVs (25, 33) and two published PToVs (Accession # JQ860350 and KM403390) all shared 103 the 5'-TGACGT-3' sequence, whereas equine ToV showed 5'-ACGT-3' (74). Whether the differences observed 104

in the BToVs were due to the intrinsic features of BToV or due to suboptimal experimental condition of the 105 5' RACE method remained unclear. However, 5'-TGACGT-3, previously reported in published BToVs and 106

PToVs, was found in only one out of seven in our analysis, whereas 5'-ACGT-3' reported in equine BToV is a 107 consensus sequence. Thus, in this study, the sequence at 5' terminal end of BToV was set as 5'-ACGT-3'. Two 108

BToV clones showed the same sequence; from these, one was selected as the parent virus (wtBToV). 109 110

Construction of a full-length BToV genome in BAC.

Full-length BToV (Aichi strain) genome cDNA was assembled into the pBeloBAC11 plasmid carrying 112 cytomegalovirus (CMV) immediate-early promoter, hepatitis delta virus ribozyme (Rz), and bovine growth 113 hormone (BGH) termination, and the cDNA was inserted downstream off the CMV promoter and flanked by 114 a 25-poly(A) sequence. The BToV genome cDNA was amplified into eight PCR fragments (BToV-A to H) 115 carrying homology arms (hms) at both terminals, and these were sequentially assembled (Fig. 1A) using the 116

Red/ET recombination method described in the Materials and Methods (Fig. 1B) . After assembly of the eight 117 fragments, the BAC carrying the full-length BToV genome cDNA (pBAC-BToV mut1 ) contained two single 118 mutations at nucleotide (nt) G3399Tand at nt T8469G, and the 1,350 bp E. coli chromosomal derived plasmid, two gene makers were inserted into the HE gene at nt T26530C and T26554A (both silent) (pBAC-126

BToV) (Fig. 2B ). pBAC -BToV was first transfected into nonpermissive 293T, COS7, BHK, Vero, and Huh7  127  cells because of the very low transfection efficiency of permissive HRT18 cells. Of these cells, 293T showed  128  the best virus production with no clear cytopathic effect (CPE), and the viral titer of the supernatant 3 days  129 post-transfection (dpt) averaged 1.0 × 10 4.1 TCID50/ ml (N=3), suggesting that the host range specificity of 130

BToV, which was difficult to propagate in cultured cells, was primarily determined by the entry step, which 131 was also observed in CoVs (47, 59, 63). The supernatant from transfected 293T was inoculated into permissive 132 HRT18 cells, after which the virus was plaque-purified three times, and then the purified virus was used to 133 characterize phonotypic properties. CPE and plaque morphology induced or formed by rBToV were identical 134 to parental wtBToV ( Fig. 3B and 4A ). Comparison of the full-length genome sequence between rBToV and 135 wtBToV showed complete sequence identities except for two gene markers (Fig. 3C ). To compare growth 136 kinetics between rBToV and wtBToV, HRT18 cells were infected with a multiplicity of infection (MOI) of 0.001, 137

and supernatants were harvested at the indicated times. rBToV and wtBToV had indistinguishable growth 138

properties in HRT18 cells and had peaked titers of >1.0 × 10 6.4 TCID50/ml at 48 h post infection (pi) (Fig. 4D) . 139

Thus, a full-length infectious cDNA clone of BToV in the BAC system was successfully constructed, and 140

features of the rescued rBToV and parental wtBToV had the same phenotypic properties in HRT18 cells. were generated (designated as rHEf, rHEf/HA, rHEs/HA, and rBToV was written as rHEs together here, 151 respectively) (Fig. 3A ). All these recombinant BToVs were successfully rescued using the same method 152 described in rBToV. They displayed no significant differences in plaque morphology and CPEs (data not  153 shown) in HRT18 cells compared to parental wtBToV and rBToV (rHEs) (Fig. 4A ). To detect HEf or HA-tagged HEf and HEs proteins, HRT18 cells infected with recombinant BToVs were fixed at 24 hpi. The cells were 155 then subjected to an α-NA esterase assay or to indirect immunofluorescence (IF) using mouse anti-M and  156  anti-HE antiserum or using rabbit anti-HA and mouse anti-HA 12CA5 antibodies. Stained cells were  157 observed under confocal laser scanning microscopy (Fig. 4B ). M proteins were detected similarly in all 158 cells infected with the recombinant BToVs, and HE proteins and α-NA esterase activity were observed 159 only in cells infected with rHEf and rHEf/HA. On the other hand, HEs/HA proteins were well stained 160 by both anti-HA antibodies (only rabbit anti-HA antibody was shown), whereas HEf/HA protein was 161 barely stained despite being well detected by mouse anti-HE antiserum (Fig. 4B ). We next tried to detect 162 HEf/HA by immunoblotting. Infected cells were lysed, and detection was performed using rabbit anti -N 163 antiserum and two anti-HA antibodies. With similar detection of N proteins in all infected cells, HEs/HA 164 could be detected in both anti-HA antibodies similar to IF results, whereas HEf/HA could not be detected by 165 rabbit anti-HA but could only be detected by the mouse anti-HA 12CA5 antibody (Fig. 4C ). To investigate 166

whether the different reactivity of the C-terminal HA-tag was due to the modification of the HA-tag in the 167 cytoplasm by either an infected cell metabolic change or viral proteins, HA-tagged proteins in COS7 cells 168

transiently expressing HEf/HA and HEs/HA were attempted to be detected in the same way. Both HA-tagged 169 proteins could be stained in IF (data not shown), but reactivity did not change in immunoblotting (Fig. 4C ). 170

Although we could not rule out the possibility that differences were due to the modification or due to the 171 expression level of HA-tag of HEf/HA in infected cells from IF results, immunoblotting results at least 172

suggested that the C-terminal HA-tag of HEf/HA had the specific structure that affects reactivity of the anti-173 HA antibodies. Finally, to compare growth kinetics, HRT18 cells were infected with these recombinant BToVs 174 with a MOI of 0.001. All these recombinant BToVs, wtBToV, and rBToV (rHEs) had no significant differences 175 in growth properties (Fig. 4D ). These results indicated that recombinant BToVs could express full-length HE 176

and HA-tagged proteins in infected cells with growth ability comparable to those of the parental wtBToV and 177

to rBToV (rHEs) 178 179

Full-length HE gene stability of rHEf and rHEf/HA 180 To assess stability of the full-length HE gene of rHEf and rHEf/HA, HRT18 cells were infected with two 181 clones (No.1 and No.2) derived from different plaques of each virus, and viruses were serially passaged until 182 twenty passages (P20). Cells were infected with the viruses harvested at the indicated passage history and were fixed or lysed at 24 hpi, and then subjected to either α-NA esterase assay or N protein-detection by 184 immunoblotting (Fig. 5A and 5B ). N proteins were detected in all infected cells (Fig. 5B compared to the parent wtBToV (Fig. 6A ). To detect EGFP in infected cells, infected cells at 36 hpi were 211 observed under fluorescence microscope, or fixed, permeabilized, stained with mouse anti-M antiserum, and observed under confocal laser scanning microscopy (Fig. 6B ). EGFP-expressions were observed only in cells 213

infected with rEGFP but not with wtBToV and rBToV, and cells expressing EGFP always also expressed M 214 protein (Fig. 6B ). These infected cells were next subjected to N protein and EGFP detection by 215

immunoblotting. Although the amount of N protein in the rEGFP-infected cells was significantly less than 216 that of cells infected with wtBToV and rBToV, EGFP was only detected in rEGFP-infected cells (Fig. 6C ). 217

Comparison of growth kinetics among rEGFP, wtBToV, and rBToV showed that rEGFP significantly 218 decreased growth ability. In four independent experiments, no virus could be detected at 24 hpi, and peak 219 titer 1.0 × 10 3.8-4.6 TCID50/ml was observed at 48 to 72 hpi in three experiments, which decreased by >2 log 220 compared to parent viruses (Fig. 6D ). In one experiment, peak titer reached 1.0 × 10 6.6 TCID50/ml at 72 hpi, 221 but the virus no longer expressed EGFP (Fig. 6D ). These data indicated that rEGFP could express EGFP in 222 infected cells but significantly decreased its growth properties. Moreover, rEGFP seemed to readily lose 223 EGFP-expression during virus growth. 224

To study EGFP gene stability, HRT18 cells were infected with rEGFP, and viruses were serially passaged 225 until five passages (P5). Cells were infected with rEGFP harvested at the indicated passage history and were 226 observed under a fluorescence microscope (Fig. 7A) were analyzed, and it was found that a large part of the EGFP gene was deleted ( Fig. 7D ), suggesting that 231 rEGFP readily lost EGFP-expression due to deletion of EGFP gene after one passage. 232 233 Improvement of EGFP-expression and growth properties in rEGFP variant but EGFP-expression was still observed in infected cells even at P9 to an extent (data not shown). The major 242 bands of P15 rEGFP No.5 (and P6 No.6: data not shown) were analyzed by sequencing, and a part of the 243 EGFP gene was deleted (Fig. 7D ). Similar to RT-PCR results, immunoblotting of N protein and EGFP of 244 rEGFP showed that EGFP-expression level of No.5 was maximized at P5, and this gradually decreased until 245 P11 (Fig. 7C ). It should be noted that the EGFP-expression level or growth property seemed to dramatically 246 increase compared to that of P0 rEGFP No.5. 247

To further investigate P5 rEGFP No.5, this was plaque-purified three times and three clones were expanded 248 (designated rEGFP c1-c3). These variants formed similar plaque morphologies to wtBToV and rBToV ( Fig.  249 8A). Comparing growth kinetics among rEGFP c1-c3, wtBToV, and rBToV showed that their peak titer 250 reached 1.0 × 10 6.5-7.2 TCID50/ ml at 72 hpi, which is comparable to that of the parental viruses, although the 251 peak was reached one day slower (Fig. 8B ). Cells infected with rEGFP c1-c3 were lysed at 24 hpi, and these 252 lysates were then subjected to N protein and EGFP detection. The result indicated that EGFP-expression 253 levels in these rEGFP c1-c3 were dramatically improved compared to P0 original virus (Fig.8C ). Analysis of 254 the full-length genome sequence of rEGFP c1 revealed five aa substitutions at G1001S, C1442F, T2129I in 255 NSP1, I3562T in NSP4, and I5327V in NSP10 (Helicase), respectively, strongly suggesting that these 256 accumulated mutations in NSPs were involved in this phenotype (Fig.8D ). Finally, EGFP gene stability in 257 rEGFP c1-c3 were investigated. As shown in Fig. 8E , these variants tend to stably express EGFP until P4, 258 but smaller bands due to the deletion of the full-length HE gene were mainly observed, with EGFP-expression 259 decreasing until P6 (data not shown in rEGFP c3). Sequencing the major band of P7 rEGFP c1-c3 showed 260 deletion of the EGFP gene, similar to those observed in other rEGFP (Fig.7D ). These data indicated that any 261 or all of the five mutations in NSPs would contribute to some acceptance of exogenous gene such as EGFP 262 gene, resulting in improved EGFP-expression and viral growth in cells, although the EGFP gene was 263 eventually lost 264 265

In this study, we successfully constructed a full-length infectious BToV cDNA clone in a bacterial artificial 267 chromosome. To our knowledge, this is the first reverse genetics system for the new family Tobaniviridae. PEDV and FIPV into low copy BAC plasmid (58, 75), but were seen in the subcloning of the TGEV cDNA 279 fragment into high copy plasmids (47). The position wherein the E. coli sequence is inserted is similar in both 280 (BToV at nt 10,136 and TGEV at nt 9,973), suggesting that these regions (BToV is in 3C-like protease) were 281 particularly toxic in bacteria in ToVs and CoVs. Though it remains unclear whether very small amounts of 282 3C-like protease in E. coli or, functional viral proteins cleaved by this protease causes toxicity, the E. coli-283 derived sequence was inserted not when the BToV-C fragment containing the 3C-like protease gene was 284 assembled but when the full-length 1ab gene (BToV-F fragment) was assembled. For BToV, since insertion of 285 the E. coli-derived sequence was observed even in low copy BAC plasmid, this region may be more toxic than 286 that of CoV or Red/ET recombination method may be prone to this. Thus, to establish other BAC-based ToV 287 reverse genetics using this method, it may be better to counter the toxic region (3-C like protease gene) 288

beforehand with an E. coli-derived sequence flanked by type IIS restriction enzymes for subsequent in vitro

Characterization of recombinant BToV with manipulating HE gene. 292

Since cell-adapted BToV generally lost the full-length HE gene, HE protein is not essential for viral growth 293

in cells or could suppress growth (34-37, 69). To study this, we generated rHEf with full-length HE gene and 294 rHEf/HA, rHEs/HA with HA-tagged HEf, or HEs gene. Comparing their growth kinetics to wtBToV and 295 rBToV (rHEs) showed no significant differences; however, during serial passaging of two clones from each 296 rHEf and rHEf/HA , each clone lost the full-length HE gene, supporting the above idea. In contrast, each the 297 other clone could retain the full-length-HE gene at least until twenty passages. This was unexpected because 298

another BToV (Niigata strain) isolated from a clinical sample in our laboratory easily lost the full-length HE 299

gene somewhere due to a stop codon insertion until eight passages during cell-adaptation (Islam and Taguchi,  300 unpublished data). Thus, the negative effect on HE protein in the cells of cell-adapted Aichi-BToV may be 301 lower than that of non-cell-adapted Niigata-BToV. Furthermore, HE proteins of cell-adapted Aichi-BToV may 302

have some advantage in terms of viral growth in the cells.

HE proteins are retained not only in ToV, but also in some of the beta CoVs (79 could all stably express reporter proteins, with their growth abilities comparable to or slightly reduced 333 compared to the parent virus. In contrast, rFGFP in which the HE gene, which is also an accessory gene, was 334 substituted with EGFP gene, could express a fluorescent protein, but it showed significantly reduced growth 335 compared to parental wtBToV, as well as less EGFP-expression. Furthermore, rEGFP easily lost EGFP-336 expression ability after only one passage due to the deletion of HE genes. Since EGFP itself is a neutral 337 protein, which probably does not give any advantage or disadvantage to viral growth in cells, whereas rEGFP 338 with deleted EGFP gene increased in terms of growth properties (Fig.6D ), EGFP gene itself rather than 339

EGFP would lead to a significant decrease in viral growth. It is interesting to note that, despite eight 340 independent experiments, starting points of HE deletion in the five were concentrated at around specific 341 positions, namely nt 24, 27, 28, and 30, and likewise the end points of the four were concentrated at around 342 nt 668, 671, 673, and 690 (Fig.7D) , suggesting that "specific negative positions" of the EGFP gene are easily 343 recognized and deleted. Deletion patterns of the EGFP gene showed that in many cases, a large part of or the 344 entire EGFP, even including a part of the transcription-regulating sequence of EGFP (HE) and, the 345 untranslated region between EGFP (HE) and the N genes, were deleted, whereas a relatively short deletion 346 leading to retention of more than 80% of the EGFP gene was also observed (Fig. 7D ). All rEGFP with deleted 347 genes rapidly replaced intact rEGFP, likely under negative selection of EGFP genetic structure. Immuno  400 Research, PA, USA) were purchased. Two Alexa Fluor TM 594-conjugated goat anti-mouse and two FITC-401 conjugated goat anti-mouse antibodies were mixed 1:1, respectively, and were used. 402 403

Plaque assay 404 HRT18 cells were seeded onto 6-well plates with 1.0 × 10 6 cells/well. The next day, the cells were inoculated 405

with 400 μL of diluted virus in order to form 10-20 plaques per well and incubated at 37°C for 1.5 h. 406

Unabsorbed virus were removed and cells were overlaid with MEM (Sigma-Aldrich) containing 0.65% agarose (Nacalai tesque, Kyoto, Japan), 2nM L-glutamine (Sanko Junyaku Co., Tokyo, Japan), 10mM HEPES 408 (Dojindo, Kumamoto, Japan) and PS, and these were incubated at 37°C until the appropriate sized plaque 409

were observed (approx. three days). Cells were fixed with 10% formaldehyde (Fujifilm Wako) and stained 410 with crystal violet. For plaque purification of virus, without cell fixation, a well-isolated plaque was picked 411

and resuspended in 100 μL DMEM(-) and stored at -70°C. Then, a 50 μL aliquot from the 100 μL plaque 412 solution was expanded in HRT18 cells with DMEM(-) in a 10 cm dish, and then these viruses were harvested 413 after the appropriate CPE was observed and was stored at -70°C as a master stock. length cDNA of the BToV genome was assembled under the control of the CMV promoter and was flanked at 437 the 3'-terminal end by a poly(A) tail (Fig. 1A) , using a Red/ET recombination system counterselection BAC 438 modification kit (Gene Bridges Heidelberg, Germany) according to the manufacturer's instructions (Fig. 1B) (Fig. 1B) . To use this system, the full-449 length genomic sequence of BToV was divided into eight fragments flanked by the hms and was assembled 450 into the BAC plasmid in a sequential order (Fig. 1A) . overlapping between the fragments, respectively. The 3' terminal hm of all fragments is the region including 458

Rz and BGH, which is (606) to (1,001) (Fig. 1A) . Fragments BToV-A to -G were prepared using standard PCR 459 protocols with the overlap extension technique (72). Fragment BToV-H was prepared through PCR using a 460 plasmid template containing a chemically synthesized BToV sequence between nt 27,987 to 28,313, 25 nt of 461 adenine (pA), and the hm of the 3' terminal sequence described above (Eurofins, Luxembourg, Luxembourg). 462

All fragments were amplified using KOD Plus Neo (TOYOBO, Osaka, Japan) and purified with gel-extraction 463 and phenol-chloroform extraction before electroporation. After assembly of the eight fragments, BAC 464 carrying the cDNA clone of the full-length BToV (pBAC-BToV mut1 ) contained three mutations, namely, two 465 single mutations at nt G3399T (E871D in NSP1 protein) and at nt T8469G (silent), and the E. coli 466 chromosomal derived sequence of 1,350 bp was inserted at nt 10,136 ( Fig. 2A) poly(A), Rz, and BGH, 28,150 to (1,001), using pRed/ET recombination (Fig. 2B) . The resulting BAC with the 482 rpsL/Neo cassette (pBAC-BToV HE/N-rpsL/Neo ) allows manipulation of not only the HE gene but also the N gene. 483

The rpsL/Neo cassette was replaced with the mutated HE gene or with the Enhanced Green Fluorescent 484

Protein (EGFP) gene (Fig. 2B) 293T and HRT18 cells were seeded into 24-well plates at 1.5 × 10 5 and 2.0 × 10 5 cells/well, respectively, on 498 the day before the experiment. 293T cells were transfected with 2.0 μg pBAC-BToV or -HE mutant and -499 EGFP with 1.5 μL Lipofectamine 3000 and 1.0 μL P3000 Regent (Thermo Fisher Scientific) and incubated at 500

37°C. The next day, DMEM(+) was replaced with 500 μL DMEM(-) to remove FBS. After 3 dpt, supernatants 501

were harvested. The 50 μL supernatant was inoculated to susceptible HRT18 cells which had been washed 502 with phosphate buffered saline (PBS) twice after which 450 μL DMEM (-) was added. After 2 dpi, 503

supernatants were harvested and viruses were plaque-purified three times. A 20 μL aliquot from the 100 μL 504 plaque suspension was added to HRT18 cells with 480 μL DMEM(-) in 24-well plates, and the supernatant 505 was harvested after 2 dpi. This was stored at -70°C as a master virus. Next, 100 μL of the master viruses 506

were expanded on HRT18 cells with 10 mL DMEM(-) in a 10 cm dish, and these viruses were harvested after 507 the appropriate CPE was observed. These were stored as passage 0 (P0) viruses, which were used for 508 subsequent experiments. In the case of rEGFP, plaque purification of some recombinant viruses (No.3 to 509

No.6) were omitted because of EGFP gene instability. 293T cells prepared on a 3 cm dish were transfected 510 with 5 times reagent volumes and pBAC-BToV-EGFP. The 2.5 mL supernatants of transfected HRT18 cells 511

were inoculated into the cells in a 10 cm dish to expand the viruses, and these viruses were then harvested. 512

In this case, these were used as passage 0 (P0) viruses. The nomenclature of recombinant BToV rescued from 513 these BAC plasmids was rBToV(rHEs), rHEf, rHEs/HA, rHEf/HA and rEGFP, respectively (Fig. 3A) . 514 515

Immunofluorescence staining 516 A 35 mm glass base dish (12 mm glass area) (Iwaki, Shizuoka, Japan) was seeded with 1.0 × 10 5 HRT18 cells, 517

the day before the experiment. Cells were washed twice with PBS and infected with 300 μL recombinant 518

BToV in DMEM(-) with a MOI of 0.05. After 24 hpi (and 36 hpi only for the rEGFP), infected cells were 519 washed with PBS, fixed with 4% paraformaldehyde for 20 min at room temperature (rt), and were permeabilized with 0.2% Triton X-100 for 20 min at RT. Cells were incubated with mouse anti-HE, anti-M 521 antiserum, or rabbit and mouse anti-HA antibodies at 4°C overnight, and were then incubated with a mixed 522 FITC-conjugated goat anti-mouse or mixed AlexaFluor TM 594-conjugated goat anti-mouse for mouse 523 antiserum and FITC-conjugated goat anti-rabbit antibodies for rabbit antibody, for 2 h at rt. Cell nuclei were 524 stained with Hoechst 33258 solution (Dojindo) for 20 min at rt. PBS washing was done twice between each 525

step. Stained cells were observed under confocal laser scanning microscopy using an LSM 710 laser scanning 526 microscope (Carl Zeiss, Oberkochen, Germany). were lysed with 100 μL sample buffer (50 mM Tris, 2% SDS, 0.1% bromophenol blue, 10% glycerol, and 1% 539 2-mercaptoethanol) and were boiled for 5 min. N protein, EGFP, and HA-tagged proteins of samples were 540 analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and were transferred to 541 a PVDF membrane (Merck Millipore, Tokyo, Japan). The membrane was incubated with rabbit anti-N 542 antiserum or mouse anti-GFP antibody, and then with HRP-conjugated anti-rabbit and anti-mouse 543 antibodies, respectively. To detect HA-tagged proteins, mouse-anti-HA 12CA5 antibody for HA-tagged HEf 544

and rabbit anti-HA antibody for HA-tagged HEs were used because of differences in their reactivity. Protein 545 bands were visualized with ECL Prime Western Blotting Detection Reagent (GE Healthcare, IL, USA) on a 546

Light Capture II instrument (ATTO, Tokyo, Japan). 547 548

Growth kinetics of recombinant BToVs 549 HRT18 cells in 24-well plates were washed twice with PBS and were infected with recombinant BToVs with 550 a MOI of 0.001. After 1.5 h adsorption at 37°C, unadsorbed viruses were removed and cells were washed 551 twice with PBS, and 0.5 mL DMEM(-) was added. Viruses in the supernatant were collected at 2, 24, 48, and 552 72 hpi and the supernatant was clarified by centrifugation at 12,000 rpm for 5 min at 4°C. Virus titers in the 553 culture media were determined in a 96-well plate by TCID50, as previously described (73). 554 555

Measurement of the stability of HE and EGFP gene 556 HRT18 cells in a 24-well plate were washed twice with PBS after which 0.5 mL DMEM(-) was added; these 557

were then infected with recombinant BToVs with a MOI of 0.001. After the appropriate CPE was observed (2 558 to 3 dpi), the supernatant was harvested and 0.5 uL was inoculated to the fresh cells, resulting in a serial 559 passages by 1,000-fold diluted virus. To estimate stability of the HEf and EGFP genes during serial passages, 560

HRT18 cells in a 24-well plate were infected with rHEf and rHEf/HA harvested at the indicated passage 561 history with a MOI of 0.05, and cells at 24 hpi were subjected to an α-NA esterase assay or to immunoblotting 562 of N proteins. EGFP-expression of the infected cells with rEGFP were monitored during serial passages under 563 a fluorescence microscope (Olympus CKX41 U-RFLT50; Olympus, Tokyo, Japan). Later, images of cells 564

infected with rEGFP harvested at the indicated passage history at the same conditions were taken, and 565 EGFP and N proteins were detected by immunoblotting. Supernatants of the infected cells (resulting in +1 566 passage history) were subjected to RNA extraction, RT-PCR, and sequencing described above. PCR fragments 567 of 1130 and 1630 bp containing HE and EGFP genes, respectively, were amplified using Takara ExTaq 568 (Takara) under the following conditions [94°C, 5min; 30 cycles of (94°C, 30 s; 50°C, 30 s; 72°C, 1 min/kb); 569

72°C 10min]. DNase treatment was also performed before RNA extraction to digest BAC plasmid from 570 transfection, depending on passage history. 571 572 genes. Viruses at P19 were plaque-purified once and six well-isolated plaques were picked, and then these 632 viruses were inoculated into fresh HRT18 cells. The HE gene of each supernatant was amplified and 633 sequenced. 5/6 means that 5 out of 6 plaques have the HE proteins described in figure Analysis of EGFP-expression and EGFP gene of these viruses during serial passages are described in Fig.7 

ICTV (International Committee on Taxonomy of Virus). 2019. Virus Taxonomy: 2019 Release

Breda virus associated with respiratory disease in 687 calves

Characterization of torovirus from human 689 fecal specimens

Identification and 691 characterization of a porcine torovirus

Studies with an unclassified virus isolated 693 from diarrheic calves

Purification and Partial Characterization of a New Enveloped 695 RNA Virus (Berne Virus)

Detection and characterization of bovine 697 torovirus from the respiratory tract in Japanese cattle

Detection of bovine torovirus in fecal specimens from calves with 15

Detection of bovine torovirus in fecal specimens of 714 calves with diarrhea from Ontario farms

First Detection and Genomic Characteristics of Bovine Torovirus in Dairy 716 Calves in China

Molecular epidemiology of Porcine torovirus (PToV) 718 in Sichuan Province

Sequencing and Genetic Analysis of a Japanese Porcine Torovirus Strain Detected in Swine Feces

Detection and molecular characterization of porcine toroviruses in Korea

Longitudinal serological and 725 virological study on porcine torovirus (PToV) in piglets from Spanish farms

Primary structure and post-741 translational processing of the Berne virus peplomer protein

Hemagglutinin-esterase, a novel structural protein of torovirus

Phylogenetic and 745 evolutionary relationships among torovirus field variants: evidence for multiple intertypic recombination 746 events

Evolution and 748 homologous recombination of the hemagglutinin-esterase gene sequences from porcine torovirus

Whole genome analysis of Japanese bovine toroviruses reveals natural recombination between porcine 753 and bovine toroviruses

Tsunemitsu 755 H. 2012. Characterization of epidemic diarrhea outbreaks associated with bovine torovirus in adult cows

Hosts and Sources of Endemic Human 769

Identification of a novel coronavirus in patients with severe acute 774 respiratory syndrome

Newly discovered 778 coronavirus as the primary cause of severe acute respiratory syndrome

Isolation of a novel 780 coronavirus from a man with pneumonia in Saudi Arabia

A pneumonia outbreak associated 784 with a new coronavirus of probable bat origin

Recombination and mutagenesis of DNA-sequences using PCR. In Directed 854 mutagenesis: a practical approach

A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT 856 ENDPOINTS12

Discontinuous and non-discontinuous 858 subgenomic RNA transcription in a nidovirus

S1 Subunit of Spike Protein from a 860

Current Highly Virulent Porcine Epidemic Diarrhea Virus Is an Important Determinant of Virulence in 861 Piglets

MERS coronavirus nsp1 participates in an 863 efficient propagation through a specific interaction with viral RNA

Two-amino acids change in the 865 nsp4 of SARS coronavirus abolishes viral replication

Transgene 867 expression in the genome of Middle East respiratory syndrome coronavirus based on a novel reverse 868 genetics system utilizing Red-mediated recombination cloning

de Grootsubgenomic RNA transcription in a nidovirus

Transcriptional and 910 Translational Landscape of Equine Torovirus